Debt-to-equity of Phathom Pharmaceuticals, Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Phathom Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • Phathom Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -182%, a 45% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Phathom Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -182% +148% +45% 30 Sep 2025
Q2 2025 -211% +170% +45% 30 Jun 2025
Q1 2025 -236% +438% +65% 31 Mar 2025
Q4 2024 -275% +475% +63% 31 Dec 2024
Q3 2024 -330% +261% +44% 30 Sep 2024
Q2 2024 -381% +166% +30% 30 Jun 2024
Q1 2024 -675% -210% -45% 31 Mar 2024
Q4 2023 -750% +389% +34% 31 Dec 2023
Q3 2023 -591% -1473% -167% 30 Sep 2023
Q2 2023 -546% -824% -297% 30 Jun 2023
Q1 2023 -465% -591% -469% 31 Mar 2023
Q4 2022 -1139% -1225% -1422% 31 Dec 2022
Q3 2022 882% +816% +1243% 30 Sep 2022
Q2 2022 278% +225% +429% 30 Jun 2022
Q1 2022 126% +80% +176% 31 Mar 2022
Q4 2021 86% +47% +119% 31 Dec 2021
Q3 2021 66% +37% +130% 30 Sep 2021
Q2 2021 53% -28% -35% 30 Jun 2021
Q1 2021 46% 31 Mar 2021
Q4 2020 39% 31 Dec 2020
Q3 2020 29% 30 Sep 2020
Q2 2020 81% 30 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.